LDL apheresis or PCSK9 inhibition? Sometimes we have to combine them

Authors :: József Balla
Bíborka Nádró
György Paragh
Lilla Juhász
Mariann Harangi
Source :: Vessel Plus. 1
Publication Year :: 2017
Publisher :: OAE Publishing Inc., 2017.
Abstract: KA

Subjects :: medicine.medical_specialty
business.industry
PCSK9
Orvostudományok
Familial hypercholesterolemia
Klinikai orvostudományok
medicine.disease
chemistry.chemical_compound
Endocrinology
chemistry
LDL apheresis
Low-density lipoprotein
Internal medicine
medicine
Low density lipoprotein apheresis
business

Tools